Alembic Pharmaceuticals receives US FDA nod for hypertension drugs

The Vadodara-based Alembic Pharmaceuticals has received final approval from US Food and Drug Administration (FDA) for its abbreviated new drug applications (ANDAs) for olmesartan medoxomil tablet (5 mg, 20 mg & 40 mg) and olmesartan medoxomil with hydrochlorothiazide tablet (20/12.5 mg, 40/12.5 mg and 40/25 mg).